Sareum operates a lean business model to deliver the most productive return for our research spend. This is accomplished by:
- maintaining a low cost base by having a small in-house team
- undertaking laboratory-based research using external providers
- engaging in research and development collaborations to share costs and access expertise
- having access to a worldwide network of expert research providers to progress programmes
- pursuing multiple drug development programmes to reduce the risk to the company
The goals are to build value by progressing our research programmes through early clinical development and generate revenues by licensing them to pharmaceutical company partners.
Find out more about our partners and current collaborations.